UC College of Medicine Names Pharmacology and Cell Biophysics Chair
CINCINNATI
Kranias serves on the research committee of the American Heart Association, on the executive committee of the International Society of Heart Research and as treasurer of the North American Section of the International Society of Heart research.
She is also a founding fellow of the International Society of Heart Research and is involved in a number of other organizations that promote the widespread distribution of heart information and research.
Dr. Kranias has been an attribute to our university and the college for almost 30 years and has done a tremendous job of leading cardiovascular research within the department of pharmacology and cell biophysics, said David Stern, MD, dean of the
Were fortunate to have her take on this role.
A native of
Kranias has also collaborated with many physicians, nationally and internationally, on basic research, particularly in the areas of impaired calcium homeostasis in heart failure, and has assumed many national and international leadership roles.
A 1966 Fulbright Scholar, Kranias is the author of over 200 peer-reviewed publications, has been an invited speaker throughout the world, has served on editorial boards and has participated and chaired numerous grant review panels and NIH study sections.
She was also named one of 2007s Leading Women for Womens Advocacy.
I am very honored to be appointed to this position, she says. I feel excited and challenged about leading the department in new dimensions of research excellence, promoting the talents of each faculty member as we move forward and making a difference within the UC College of Medicine.
Kranias will be replacing Robert Highsmith, PhD, who has served as interim chair of the department since March 2007. Highsmith is currently the associate vice president for research at UC and the senior associate dean and director of the office of research and graduate education in the
Litsa Kranias, PhD, chair of UCÂ s department of pharmacology and cell biophysics
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.